CAD 7.08
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.15 Million USD | 274.31% |
2022 | 576 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 75 Thousand USD | -39.02% |
2008 | 123 Thousand USD | -33.51% |
2007 | 185 Thousand USD | 96.81% |
2006 | 94 Thousand USD | 59.32% |
2005 | 59 Thousand USD | 0.0% |
2003 | 151.12 Thousand USD | -54.05% |
2002 | 328.88 Thousand USD | 30.53% |
2001 | 251.95 Thousand USD | 25142223633601.11% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 2.06 Million USD | -4.27% |
2024 Q2 | 2.14 Million USD | 3.88% |
2023 FY | 2.15 Million USD | 274.31% |
2023 Q3 | 1.75 Million USD | 21.96% |
2023 Q4 | 2.15 Million USD | 22.85% |
2023 Q1 | 918 Thousand USD | 59.38% |
2023 Q2 | 1.43 Million USD | 56.75% |
2022 Q2 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q4 | 576 Thousand USD | 0.0% |
2022 FY | 576 Thousand USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2011 Q1 | 29 Thousand USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | -100.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | -100.0% |
2010 Q1 | 75 Thousand USD | 0.0% |
2010 FY | - USD | -100.0% |
2010 Q3 | - USD | 0.0% |
2009 Q4 | 75 Thousand USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q1 | - USD | -100.0% |
2009 FY | 75 Thousand USD | -39.02% |
2008 Q3 | 109 Thousand USD | 1.87% |
2008 Q1 | 109 Thousand USD | -41.08% |
2008 Q4 | 123 Thousand USD | 12.84% |
2008 Q2 | 107 Thousand USD | -1.83% |
2008 FY | 123 Thousand USD | -33.51% |
2007 Q2 | 114 Thousand USD | 0.0% |
2007 FY | 185 Thousand USD | 96.81% |
2007 Q4 | 185 Thousand USD | -9.31% |
2007 Q3 | 204 Thousand USD | 78.95% |
2007 Q1 | 114 Thousand USD | 21.28% |
2006 FY | 94 Thousand USD | 59.32% |
2006 Q4 | 94 Thousand USD | 11.91% |
2006 Q3 | 83.99 Thousand USD | -29.41% |
2006 Q2 | 118.99 Thousand USD | 15.53% |
2006 Q1 | 102.99 Thousand USD | 74.57% |
2005 Q4 | 59 Thousand USD | -42.15% |
2005 FY | 59 Thousand USD | 0.0% |
2005 Q2 | 90 Thousand USD | 7.15% |
2005 Q3 | 101.99 Thousand USD | 13.32% |
2005 Q1 | 83.99 Thousand USD | 0.0% |
2004 Q2 | 151.12 Thousand USD | -63.96% |
2004 Q1 | 419.33 Thousand USD | -16.38% |
2004 Q3 | 79 Thousand USD | -47.72% |
2003 Q1 | 329.91 Thousand USD | 1.86% |
2003 Q2 | 328.88 Thousand USD | -0.31% |
2003 Q3 | 315.39 Thousand USD | -4.1% |
2003 Q4 | 501.47 Thousand USD | 59.0% |
2003 FY | 151.12 Thousand USD | -54.05% |
2002 FY | 328.88 Thousand USD | 30.53% |
2002 Q3 | 244.57 Thousand USD | -2.93% |
2002 Q1 | 61.6 Thousand USD | -54.61% |
2002 Q4 | 323.9 Thousand USD | 32.44% |
2002 Q2 | 251.95 Thousand USD | 309.0% |
2001 FY | 251.95 Thousand USD | 25142223633601.11% |
2001 Q3 | 37.15 Thousand USD | 3708101527596.65% |
2001 Q2 | - USD | 0.0% |
2001 Q4 | 135.7 Thousand USD | 265.21% |
2000 FY | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Appili Therapeutics Inc. | - CAD | -Infinity% |
Eupraxia Pharmaceuticals Inc. | 1.00 CAD | -215599900.0% |
Helix BioPharma Corp. | - CAD | -Infinity% |
Microbix Biosystems Inc. | 5.75 Million CAD | 62.518% |
Medicenna Therapeutics Corp. | - CAD | -Infinity% |
Satellos Bioscience Inc. | -583 Thousand CAD | 469.811% |
Oncolytics Biotech Inc. | - CAD | -Infinity% |
Sernova Corp. | - CAD | -Infinity% |